Polio Outbreak in Pakistan
Pakistan continues to be dealing with a polio outbreak as four fresh cases have emerged, pushing the national tally to 37 this year, according to health officials on October 19, 2024. Health officials said that the regional reference laboratory for polio eradication at the National Institute of Health in Islamabad confirmed wild poliovirus type-1 (WPV1) in two children-one from each Balochistan and Khyber-Pakhtunkhwa.
In recent cases, a girl has been affected from Pishin, and two boys from Chaman and Noshki of Balochistan, and a girl from Lakki Marwat in KP. These are the first detections of the virus within Noshki and Lakki Marwat this year; isolated cases of poliovirus were previously reported within Chaman and Pishin. The province of Balochistan was the worst hit with 20 cases, Sindh had 10, Khyber Pakhtunkhwa had five, and Punjab and Islamabad had one case each.
A gigantic fight against polio has been on going in Pakistan- especially in Balochistan and southern KP-over the last two years. Immunisation campaigns have often been suspended or delayed because of local protests, insecurity, and community boycotts. Consequently, quite a number of children did not get the necessary vaccinations, making existing patches of vulnerability for the virus to flow within those pockets.
Noshki, located near Afghanistan's border, and Lakki Marwat have also recently reported some positive environmental samples that confirm the virus is present here, said a local reference laboratory official. Samples of latest cases are currently under genetic sequencing for checking spread of virus and origin.
As the threat of polio continues to grow, Pakistan has vowed to mount a nationwide campaign against it beginning from October 28. With the zeal to tackle the menace in the most effective manner, over 45 million children under the age of five will be vaccinated across the country.
Today, Afghanistan and Pakistan remain one of the few countries where polio has not yet been eradicated. The WHO said the virus remains a potential serious public health threat in areas with low vaccination coverage and weak surveillance.
The country declared itself polio-free since 2014 and has kept the disease on bay almost a decade with very robust vaccination programs; however, two cases of vaccine-derived poliovirus cases reported in recent days from Meghalaya create some amount of doubts over a possible resurgence. Experts observe that in India, despite these detections taking place, strong coverage of vaccination at 90-95% and mandatory surveillance measures keep the risk of this widespread outbreak at bay.
The experts point out, however, that such stable situation in India requires continued surveillance. "Countries like Pakistan and parts of Africa remain at a high risk because vaccination rates in those areas are much lower," Dr. Siddharth, public health expert, said. Vaccination is an indispensable act in order to avoid the spread of this incapacitating disease that manifests most importantly as a nervous system affliction leading to the paralysis of a long period.
With concerted efforts from health authorities, there is hope someday that the scourge of polio will be completely eradicated from the face of the earth and future generations will never suffer from its effects.
Credit: AP Photos
After 26 years, the US has lost its measles elimination status, marking a major setback for public health efforts. The resurgence has intensified criticism of Health and Human Services Secretary Robert F. Kennedy Jr. over his vaccine policies and rhetoric.
The Pan American Health Organization (PAHO) confirmed that the US had lost the status it maintained since 2000.
The country has recorded more than 5,700 measles cases and 11 deaths. Pennsylvania, the hardest-hit state, has reported its eighth measles-associated death of 2026.
A CDC-led report identified 112 measles infections among pregnant women in the US between January 2025 and September 2026, along with 13 cases of congenital measles in newborns.
The actual number may be higher. A separate CIDRAP News investigation based on state health department data identified at least 167 pregnant women infected in 2025 and 2026.
“Even though measles is an old disease, measles in pregnancy is an emerging area that we need to learn about,” said Michelle Barton, a professor at the Schulich School of Medicine & Dentistry at Western University.
Decades of MMR vaccination meant many doctors had never encountered measles during their medical careers. However, declining vaccination rates have allowed the disease to spread in under-vaccinated communities.
Criticism of Kennedy has crossed party lines. Republican Senator Bill Cassidy of Louisiana on Sunday criticised what he called a "series of failures" under Kennedy's leadership at the Department of Health and Human Services.
"This has been a failure. If I were president, I would choose someone else because there needs to be accountability for higher health care costs, more measles deaths, losing elimination status, and no progress on processed foods," Cassidy said on CBS News.
Democratic senators Angela Alsobrooks and Patty Murray have also called for Kennedy's removal.
Alsobrooks (Maryland) condemned the loss of measles elimination status and called Kennedy's tenure a disgrace. She had called for his resignation or dismissal in May 2025. Her resolution of disapproval against Kennedy now has 28 Senate co-sponsors.
Senator Richard Blumenthal (Connecticut) has demanded answers over the alleged suppression of a CDC warning about measles risks during pregnancy, while criticising the administration's vaccine policies.
Murray (Washington) has blamed Trump and Kennedy's leadership for the loss of elimination status and repeatedly called for Kennedy's removal.
Democratic governors have also blamed Kennedy for the setback. New York Governor Kathy Hochul said the loss of measles elimination status contradicted Kennedy's promise to make America healthy again.
"RFK Jr. promised to 'Make America Healthy Again.' Now America has lost its measles-free status for the first time in 26 years," Hochul said.
"A disgraceful display of incompetence from the nation's highest public health office," she added.
Pennsylvania Governor Josh Shapiro blamed vaccine misinformation and skepticism for the setback. "There is a clear line from the misinformation, vaccine skepticism, and incompetence of RFK Jr. to this devastating news and very real consequences," Shapiro said.
Kentucky Governor Andy Beshear explicitly demanded Kennedy's removal. "This dangerous setback was 100% avoidable and is the result of one person: RFK Jr.," Beshear said. "Remove him now."
An HHS spokesperson rejected the governors' criticism in a statement to Fox News Digital, calling their attacks "baseless" and arguing that declining vaccination rates predated the Trump administration.
The spokesperson said the administration remained focused on expanding vaccine access, closing immunisation gaps and assisting state and local officials with outbreak investigations.
Kennedy has vowed to stop measles outbreaks and restore the country's elimination status while continuing to recommend vaccination.
"We will stop measles outbreaks, protect American families, and work to regain U.S. measles elimination status," Kennedy said in a statement.
"I continue to recommend MMR vaccination as the most effective way to prevent measles," he added.
Credit: iStock
In a world first, India's indigenous SSI Mantra Surgical Robotic System enabled two surgeons to perform a robotic beating-heart bypass procedure using a dual-console setup, according to SS Innovations.
The five-arm robotic system was used for a Totally Endoscopic Coronary Artery Bypass (TECAB) procedure by two surgeons from Medanta Hospital, Gurugram. The surgeons operated through separate control consoles while the patient's heart continued beating, without the use of a heart-lung machine.
They worked in synchrony using all five robotic arms. A heart stabilization system helped steady the target area during the procedure.
“The successful completion of this highly complex beating-heart TECAB procedure demonstrates how robotic surgery can make advanced cardiac interventions less invasive for patients. It is a proud moment for our team and an important step forward for cardiac surgery in India,” said Dr. Naresh Trehan, Chairman and Managing Director, Medanta.
Unlike conventional robotic cardiac procedures that typically use a single console, a dual-console configuration allows two surgeons to control the robotic system simultaneously. This can improve coordination during complex procedures.
The five-arm configuration allows multiple robotic instruments to be deployed at the same time. It also allows the second surgeon to gain hands-on experience during complex procedures, making the setup potentially useful for surgical training.
Totally Endoscopic Coronary Artery Bypass, or TECAB, is a minimally invasive form of bypass surgery performed through small incisions, without opening the chest through a conventional sternotomy.
In the beating-heart approach, surgeons perform the bypass while the heart continues beating, without stopping it or using a heart-lung machine. A stabilization system keeps the area being operated on steady.
Robotic cardiac surgery also avoids the extensive chest incision involved in conventional open-heart procedures.
The patient's recovery progress over 15 days offers an initial reference point for assessing the outcome. However, longer-term follow-up and clinical data would be needed to establish the broader benefits of this approach.
Dr. Nitin Kumar Rajput, Associate Director of Robotic and Minimally Invasive Cardiac Surgery at Medanta, said performing a complex beating-heart bypass using five robotic arms and two control consoles required precision, coordination and close collaboration between the surgeons.
“The patient's recovery following surgery was encouraging and reinforces the potential of minimally invasive techniques in advancing cardiac care,” he said.
The SSI Mantra is a modular surgical robotic system that can be configured with three to five arms. It features an ergonomic, open-faced Surgeon Command Centre, a 32-inch 3D 4K monitor and a 23-inch touchscreen for patient information.
The system also offers a real-time virtual view of the robotic arms and allows 3D models generated from diagnostic imaging to be superimposed.
Dr. Sudhir Srivastava, Founder, Chairman and CEO of SS Innovations International, Inc., said the procedure demonstrated the SSI Mantra system's potential in minimally invasive cardiac surgery and marked a major milestone for India's surgical robotics sector.
Credit: iStock
Amid rising antimicrobial resistance (AMR) worldwide, the Union Ministry of Health and Family Welfare has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, to bring antimicrobials under central regulatory oversight.
The amendment seeks to include ‘antimicrobials’ in the definition of ‘New Drug’ under Rule 2(1)(w)(v). Manufacturers would need central approval before applying for a manufacturing licence from state authorities.
"The proposal is intended to serve as an additional regulatory safeguard against antimicrobial resistance (AMR) by strengthening oversight of antimicrobial products and ensuring appropriate scrutiny of their quality, safety and efficacy before the grant of new manufacturing licences," the Ministry said.
AMR occurs when bacteria, viruses, fungi and parasites evolve and no longer respond to medicines designed to treat infections. This makes infections harder to treat, increases the risk of severe illness and death, and can complicate medical procedures such as surgery and cancer treatment.
Addressing the World Antimicrobial Resistance (AMR) Awareness Week 2026, Union Health Secretary Punya Salila Srivastava described AMR as one of the most serious public health challenges. She warned that misuse and overuse of antimicrobials could make even common infections difficult to treat and threaten decades of medical progress.
Also read: Antimicrobial Resistance Could Contribute To 39 Million Deaths By 2050: WHO
The Ministry proposed the amendment through draft Gazette Notification G.S.R. 983 (E), dated November 6.
Manufacturers would need permission from the Central Licensing Authority (CLA) before applying for a manufacturing licence from the concerned State Licensing Authority (SLA).
Existing manufacturing licences will remain valid, and holders will not need to reapply for permission.
The measure is expected to strengthen central oversight and help ensure the quality, safety and efficacy of antimicrobial products, the Ministry said.
The proposal follows concerns that antimicrobial manufacturing licences are being granted without adequate regulatory scrutiny, including bioavailability/bioequivalence (BA/BE) and stability studies.
The absence of these assessments may affect product quality, safety and efficacy. Substandard or ineffective antimicrobials can contribute to AMR and pose risks to patient safety.
"The measure is part of the Government's broader efforts to promote the responsible use of antimicrobials, safeguard patient safety and address the growing public health challenge of AMR," the Ministry said.
The amendment remains at the draft stage. The Ministry has invited objections and suggestions from stakeholders and the public before finalisation.
In addition, the Ministry has proposed amendments to the Drugs Rules, 1945, to introduce separate application and licence forms for the wholesale sale of bulk drugs, including active and inactive bulk substances.
Currently, a common licence covers the wholesale sale of both formulations and bulk drugs.
The proposed framework would allow more focused oversight of bulk drug sales and improve accountability in the pharmaceutical supply chain, the Ministry said.
Licences would specify the categories of bulk drugs handled by wholesalers, including those covered under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985. Bulk drug sales would also require the personal supervision of a competent person.
© $2026 Times Horizon Private Limited